Related Experiment Video
Updated: Jan 16, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Steroid-Refractory Immune Checkpoint Inhibitor-Induced Myocarditis Responsive to Mycophenolate and Antithymocyte
Michael J Wilson1, Jorge Dabdoub1, Matthew F Gottbrecht2
1Department of Internal Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Immune checkpoint inhibitor (ICI) therapy can cause rare myocarditis. A combination of antithymoglobulin and mycophenolate offers a promising rescue therapy for severe, steroid-refractory cases.
Area of Science:
- Cardiology
- Immunology
- Oncology
Background:
- Noninfectious myocarditis is a rare but severe adverse event associated with immune checkpoint inhibitor (ICI) therapy.
- High mortality rates characterize severe cases, necessitating prompt multidisciplinary management and often intensive care unit admission.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
